Reaction
Intestinal Polyp reporting signals
As of the last recalculation, Intestinal Polyp appears in 1,636 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 17.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 18 | 17.2 | 17.2 |
| Adalimumab | 414 | 9.6 | 9.6 |
| Cholestyramine | 9 | 9.5 | 9.5 |
| Febuxostat Tablets 40 Mg | 7 | 8.8 | 8.8 |
| Febuxostat Tablets 80 Mg | 7 | 8.8 | 8.8 |
| Hydroxychloroquine | 48 | 8.4 | 8.4 |
| Tocilizumab | 72 | 8.4 | 8.4 |
| Abatacept | 85 | 8.2 | 8.2 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 8.1 | 8.1 |
| Vedolizumab | 49 | 7.4 | 7.4 |
| Desoximetasone | 9 | 6.0 | 6.0 |
| Ticagrelor | 13 | 5.2 | 5.2 |
| Acetaminophen, Aspirin (Nsaid) And Caffeine | 6 | 4.5 | 4.5 |
| Isotretinoin | 13 | 3.4 | 3.4 |
| Pirfenidone | 8 | 2.5 | 2.5 |